The prize draw is open until 2 March. The £50,000 prize will be paid directly into the winner’s Investngine account by 30 March.
Author: techrossm
Legacy Wealth Management Unveils Family Office-Inspired Advisory Services for Smaller Investors
Legacy Wealth Management offers a family office-inspired approach to wealth management, making sophisticated financial services accessible to …
Why Brown-Forman (BF.B) stock is trading lower today
What Happened? Shares of alcohol company Brown-Forman (NYSE:BF.B) fell 3.7% in the afternoon session after BNP Paribas Exane downgraded the stock to “Underperform” from
Officials crack down on $1 billion cryptocurrency scheme: ‘Suspected of being involved’
Crypto, as a rising giant in the world of monetary transactions, is something that cannot be ignored. Officials crack down on $1 billion cryptocurrency
Invest $30,000 in 2 TSX stocks and create $1,937 in dividend income
These TSX stocks have high yields and sustainable payouts, and can help you generate a dividend income of $1,937 annually. The post Invest $30,000
Is the stock market open on Martin Luther King Day?
When is Martin Luther King Jr. Day? Martin Luther King, Jr. Day, sometimes abbreviated to MLK Day, is commemorated on the third Monday in
Sealsq: The High-Growth Quantum Stock That The Market Is Overlooking
SEALSQ Corp. posts 66% FY25 sales growth, guides 50–100% FY26 upside, and plans quantum-security M&A with $425M cash. Click for this updated look at
2 growth stocks to invest $1,000 in right now
Two of those stocks, which could turn $1,000 into a lot more money over the next decade, are Opendoor (NASDAQ: OPEN) and Nextpower (NASDAQ:
Alternative Investment Firm A.R.I. Acquires Controlling Majority Interest in Lights Out Sports
Lights Out Appoints Dr. Zack Ellison Chairman of the Board, President & Chief Executive Officer to Lead Next Phase …
Stock Market Today, Jan. 16: ImmunityBio Soars After Anktiva Revenue Jumps 700 Percent Year Over Year
Explosive Anktiva sales, new cancer data, and fresh approvals are rapidly redefining this immunotherapy story, today, Jan. 16, 2026.